A1270912
Brij™ L23 , Protein group learning level , 9002-92-0
Synonym(s):
Brij 35;Polidocanol;Lauromacrogol;Polyethylene glycol dodecyl ether;Coceth-10
CAS NO.：9002-92-0
Empirical Formula: C58H118O24
Molecular Weight: 1199.55
MDL number: MFCD00043375
EINECS: 500-002-6
| Pack Size | Price | Stock | Quantity |
| 100G | RMB51.20 | In Stock |
|
| 250g | RMB175.20 | In Stock |
|
| 1KG | RMB559.20 | In Stock |
|
| 5KG | RMB2239.20 | In Stock |
|
| others | Enquire |
Update time: 2022-07-08
PRODUCT Properties
| Melting point: | 41-45 °C(lit.) |
| Boiling point: | 100 °C(lit.) |
| Density | 0.99 g/mL±0.002 g/mL at 20 °C |
| vapor pressure | <1 mm Hg ( 20 °C) |
| refractive index | n |
| Flash point: | >230 °F |
| storage temp. | Store below +30°C. |
| solubility | H2O: 40 mg/mL at 20 °C, clear, colorless |
| pka | 0[at 20 ℃] |
| form | Waxy Pellets |
| color | White |
| PH | 5.5-7.0 (100g/l, H2O, 20℃) |
| Odor | Odorless |
| PH Range | 5.5 - 7.5 |
| Water Solubility | soluble |
| FreezingPoint | 35.0 to 40.0 ℃ |
| Merck | 14,7558 |
| Stability: | Stable. Combustible. Incompatible with strong oxidizing agents. |
| LogP | 2.26 at 25℃ |
Description and Uses
Brij L23 is a a pharmaceutical compound used in the schlerotherapy treatments, in those suffering from blood vessel malformations and mutations.
Safety
| Symbol(GHS) |   GHS07,GHS09 |
| Signal word | Warning |
| Hazard statements | H302-H315-H319-H410 |
| Precautionary statements | P264-P270-P273-P301+P312-P302+P352-P305+P351+P338 |
| Hazard Codes | Xn,Xi |
| Risk Statements | 22-41-36/37/38-38-37/38-36 |
| Safety Statements | 26-39-37/39-36/37/39-36-24/25 |
| RIDADR | UN 3082 9/PG 3 |
| WGK Germany | 3 |
| RTECS | MD0875000 |
| F | 3 |
| TSCA | Yes |
| HS Code | 34021300 |
| HS Code | 38220000 |
| Toxicity | LD50 in mice (mg/kg): 1170 orally, 125 i.v. (Zipf) |
